BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers

1. A.K. Byrum, A. Vindigni, N. Mosammaparast, Defining and Modulating ‘BRCAness’, Trends Cell Biol. 2019; 29(9): 740-751. Byrum A.K. Vindigni A. Mosammaparast N. Defining and Modulating ‘BRCAness’ , Trends Cell Biol. 2019 ; 29 ( 9 ): 740 - 751 . Search in Google Scholar

2. M.J. Khoury, W.G. Feero, D.A. Chambers, L.C. Brody, N. Aziz, R.C. Green, A. Janssens, M.F. Murray, L.L. Rodriguez, J.L. Rutter, S.D. Schully, D.M. Winn, G.A. Mensah, A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health, PLoS Med. 2018; 15(8): e1002631. Khoury M.J. Feero W.G. Chambers D.A. Brody L.C. Aziz N. Green R.C. Janssens A. Murray M.F. Rodriguez L.L. Rutter J.L. Schully S.D. Winn D.M. Mensah G.A. , A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health , PLoS Med. 2018 ; 15 ( 8 ): e1002631 . Search in Google Scholar

3. J.J. Grzymski, G. Elhanan, J.A. Morales Rosado, E. Smith, K.A. Schlauch, R. Read, C. Rowan, N. Slotnick, S. Dabe, W.J. Metcalf, B. Lipp, H. Reed, L. Sharma, E. Levin, J. Kao, M. Rashkin, J. Bowes, K. Dunaway, A. Slonim, N. Washington, M. Ferber, A. Bolze, J.T. Lu, Population genetic screening efficiently identifies carriers of autosomal dominant diseases, Nat Med. 2020; 26(8): 1235-1239. Grzymski J.J. Elhanan G. Morales Rosado J.A. Smith E. Schlauch K.A. Read R. Rowan C. Slotnick N. Dabe S. Metcalf W.J. Lipp B. Reed H. Sharma L. Levin E. Kao J. Rashkin M. Bowes J. Dunaway K. Slonim A. Washington N. Ferber M. Bolze A. Lu J.T. , Population genetic screening efficiently identifies carriers of autosomal dominant diseases , Nat Med. 2020 ; 26 ( 8 ): 1235 - 1239 . Search in Google Scholar

4. K.J. Karczewski, L.C. Francioli, G. Tiao, B.B. Cummings, J. Alföldi, Q. Wang, R.L. Collins, K.M. Laricchia, A. Ganna, D.P. Birnbaum, L.D. Gauthier, H. Brand, M. Solomonson, N.A. Watts, D. Rhodes, M. Singer-Berk, E.M. England, E.G. Seaby, J.A. Kosmicki, R.K. Walters, K. Tashman, Y. Farjoun, E. Banks, T. Poterba, A. Wang, C. Seed, N. Whiffin, J.X. Chong, K.E. Samocha, E. Pierce-Hoffman, Z. Zappala, A.H. O’Donnell-Luria, E.V. Minikel, B. Weisburd, M. Lek, J.S. Ware, C. Vittal, I.M. Armean, L. Bergelson, K. Cibulskis, K.M. Connolly, M. Covarrubias, S. Donnelly, S. Ferriera, S. Gabriel, J. Gentry, N. Gupta, T. Jeandet, D. Kaplan, C. Llanwarne, R. Munshi, S. Novod, N. Petrillo, D. Roazen, V. Ruano-Rubio, A. Saltzman, M. Schleicher, J. Soto, K. Tibbetts, C. Tolonen, G. Wade, M.E. Talkowski, B.M. Neale, M.J. Daly, D.G. MacArthur, The mutational constraint spectrum quantified from variation in 141,456 humans, Nature. 2020; 581(7809): 434-443. Karczewski K.J. Francioli L.C. Tiao G. Cummings B.B. Alföldi J. Wang Q. Collins R.L. Laricchia K.M. Ganna A. Birnbaum D.P. Gauthier L.D. Brand H. Solomonson M. Watts N.A. Rhodes D. Singer-Berk M. England E.M. Seaby E.G. Kosmicki J.A. Walters R.K. Tashman K. Farjoun Y. Banks E. Poterba T. Wang A. Seed C. Whiffin N. Chong J.X. Samocha K.E. Pierce-Hoffman E. Zappala Z. O’Donnell-Luria A.H. Minikel E.V. Weisburd B. Lek M. Ware J.S. Vittal C. Armean I.M. Bergelson L. Cibulskis K. Connolly K.M. Covarrubias M. Donnelly S. Ferriera S. Gabriel S. Gentry J. Gupta N. Jeandet T. Kaplan D. Llanwarne C. Munshi R. Novod S. Petrillo N. Roazen D. Ruano-Rubio V. Saltzman A. Schleicher M. Soto J. Tibbetts K. Tolonen C. Wade G. Talkowski M.E. Neale B.M. Daly M.J. MacArthur D.G. , The mutational constraint spectrum quantified from variation in 141,456 humans , Nature. 2020 ; 581 ( 7809 ): 434 - 443 . Search in Google Scholar

5. S.T. Sherry, M.H. Ward, M. Kholodov, J. Baker, L. Phan, E.M. Smigielski, K. Sirotkin, dbSNP: the NCBI database of genetic variation, Nucleic Acids Res. 2001; 29(1): 308-11. Sherry S.T. Ward M.H. Kholodov M. Baker J. Phan L. Smigielski E.M. Sirotkin K. , dbSNP: the NCBI database of genetic variation , Nucleic Acids Res. 2001 ; 29 ( 1 ): 308 - 11 . Search in Google Scholar

6. M.J. Landrum, S. Chitipiralla, G.R. Brown, C. Chen, B. Gu, J. Hart, D. Hoffman, W. Jang, K. Kaur, C. Liu, V. Lyoshin, Z. Maddipatla, R. Maiti, J. Mitchell, N. O’Leary, G.R. Riley, W. Shi, G. Zhou, V. Schneider, D. Maglott, J.B. Holmes, B.L. Kattman, ClinVar: improvements to accessing data, Nucleic Acids Res. 2020; 48(D1): D835-d844 Landrum M.J. Chitipiralla S. Brown G.R. Chen C. Gu B. Hart J. Hoffman D. Jang W. Kaur K. Liu C. Lyoshin V. Maddipatla Z. Maiti R. Mitchell J. O’Leary N. Riley G.R. Shi W. Zhou G. Schneider V. Maglott D. Holmes J.B. Kattman B.L. , ClinVar: improvements to accessing data , Nucleic Acids Res. 2020 ; 48 ( D1 ): D835 - d844 Search in Google Scholar

7. P.D. Stenson, M. Mort, E.V. Ball, M. Chapman, K. Evans, L. Azevedo, M. Hayden, S. Heywood, D.S. Millar, A.D. Phillips, D.N. Cooper, The Human Gene Mutation Database (HGMD(®)): optimizing its use in a clinical diagnostic or research setting, Hum Genet. 2020; 139(10): 1197-1207. Stenson P.D. Mort M. Ball E.V. Chapman M. Evans K. Azevedo L. Hayden M. Heywood S. Millar D.S. Phillips A.D. Cooper D.N. , The Human Gene Mutation Database (HGMD(®)): optimizing its use in a clinical diagnostic or research setting , Hum Genet. 2020 ; 139 ( 10 ): 1197 - 1207 . Search in Google Scholar

8. S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W.W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H.L. Rehm, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med. 2015; 17(5): 405-24. Richards S. Aziz N. Bale S. Bick D. Das S. Gastier-Foster J. Grody W.W. Hegde M. Lyon E. Spector E. Voelkerding K. Rehm H.L. , Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , Genet Med. 2015 ; 17 ( 5 ): 405 - 24 . Search in Google Scholar

9. J. O’Shaughnessy, C. Brezden-Masley, M. Cazzaniga, T. Dalvi, G. Walker, J. Bennett, S. Ohsumi, Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study, Breast Cancer Res. 2020; 22(1): 114. O’Shaughnessy J. Brezden-Masley C. Cazzaniga M. Dalvi T. Walker G. Bennett J. Ohsumi S. , Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study , Breast Cancer Res. 2020 ; 22 ( 1 ): 114 . Search in Google Scholar

10. K.B. Kuchenbaecker, J.L. Hopper, D.R. Barnes, K.A. Phillips, T.M. Mooij, M.J. Roos-Blom, S. Jervis, F.E. van Leeuwen, R.L. Milne, N. Andrieu, D.E. Goldgar, M.B. Terry, M.A. Rookus, D.F. Easton, A.C. Antoniou, L. McGuffog, D.G. Evans, D. Barrowdale, D. Frost, J. Adlard, K.R. Ong, L. Izatt, M. Tischkowitz, R. Eeles, R. Davidson, S. Hodgson, S. Ellis, C. Nogues, C. Lasset, D. Stoppa-Lyonnet, J.P. Fricker, L. Faivre, P. Berthet, M.J. Hooning, L.E. van der Kolk, C.M. Kets, M.A. Adank, E.M. John, W.K. Chung, I.L. Andrulis, M. Southey, M.B. Daly, S.S. Buys, A. Osorio, C. Engel, K. Kast, R.K. Schmutzler, T. Caldes, A. Jakubowska, J. Simard, M.L. Friedlander, S.A. McLachlan, E. Machackova, L. Foretova, Y.Y. Tan, C.F. Singer, E. Olah, A.M. Gerdes, B. Arver, H. Olsson, Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers, Jama. 2017; 317(23): 2402-2416. Kuchenbaecker K.B. Hopper J.L. Barnes D.R. Phillips K.A. Mooij T.M. Roos-Blom M.J. Jervis S. van Leeuwen F.E. Milne R.L. Andrieu N. Goldgar D.E. Terry M.B. Rookus M.A. Easton D.F. Antoniou A.C. McGuffog L. Evans D.G. Barrowdale D. Frost D. Adlard J. Ong K.R. Izatt L. Tischkowitz M. Eeles R. Davidson R. Hodgson S. Ellis S. Nogues C. Lasset C. Stoppa-Lyonnet D. Fricker J.P. Faivre L. Berthet P. Hooning M.J. van der Kolk L.E. Kets C.M. Adank M.A. John E.M. Chung W.K. Andrulis I.L. Southey M. Daly M.B. Buys S.S. Osorio A. Engel C. Kast K. Schmutzler R.K. Caldes T. Jakubowska A. Simard J. Friedlander M.L. McLachlan S.A. Machackova E. Foretova L. Tan Y.Y. Singer C.F. Olah E. Gerdes A.M. Arver B. Olsson H. , Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers , Jama. 2017 ; 317 ( 23 ): 2402 - 2416 . Search in Google Scholar

11. M. Okano, T. Nomizu, K. Tachibana, M. Nagatsuka, M. Matsuzaki, N. Katagata, T. Ohtake, S. Yokoyama, M. Arai, S. Nakamura, The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database, J Hum Genet. 2021; 66(3): 307-314. Okano M. Nomizu T. Tachibana K. Nagatsuka M. Matsuzaki M. Katagata N. Ohtake T. Yokoyama S. Arai M. Nakamura S. , The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database , J Hum Genet. 2021 ; 66 ( 3 ): 307 - 314 . Search in Google Scholar

12. S. Chen, G. Parmigiani, Meta-analysis of BRCA1 and BRCA2 penetrance, J Clin Oncol 2007; 25(11): 1329-33. Chen S. Parmigiani G. , Meta-analysis of BRCA1 and BRCA2 penetrance , J Clin Oncol 2007 ; 25 ( 11 ): 1329 - 33 . Search in Google Scholar

13. V. Sunar, V. Korkmaz, V. Topcu, B. Cavdarli, Z. Arik, B. Ozdal, Y.E. Ustun, Frequency of germline BRCA 1/BRCA 2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer, Asia Pac J Clin Oncol. 2021. Sunar V. Korkmaz V. Topcu V. Cavdarli B. Arik Z. Ozdal B. Ustun Y.E. , Frequency of germline BRCA 1/BRCA 2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer , Asia Pac J Clin Oncol. 2021 . Search in Google Scholar

14. A.L. Siu, Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement, Ann Intern Med. 2016; 164(4): 279-96. Siu A.L. , Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement , Ann Intern Med. 2016 ; 164 ( 4 ): 279 - 96 . Search in Google Scholar

15. D.P. Atchley, C.T. Albarracin, A. Lopez, V. Valero, C.I. Amos, A.M. Gonzalez-Angulo, G.N. Hortobagyi, B.K. Arun, Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer, J Clin Oncol. 2008; 26(26): 4282-8. Atchley D.P. Albarracin C.T. Lopez A. Valero V. Amos C.I. Gonzalez-Angulo A.M. Hortobagyi G.N. Arun B.K. , Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer , J Clin Oncol. 2008 ; 26 ( 26 ): 4282 - 8 . Search in Google Scholar

16. E. Lee, R. McKean-Cowdin, H. Ma, D.V. Spicer, D. Van Den Berg, L. Bernstein, G. Ursin, Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women, J Clin Oncol. 2011; 29(33): 4373-80. Lee E. McKean-Cowdin R. Ma H. Spicer D.V. Van Den Berg D. Bernstein L. Ursin G. , Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women , J Clin Oncol. 2011 ; 29 ( 33 ): 4373 - 80 . Search in Google Scholar

17. E.V. Høgdall, M. Ringsholt, C.K. Høgdall, I.J. Christensen, J.S. Johansen, S.K. Kjaer, J. Blaakaer, L. Ostenfeld-Møller, P.A. Price, L.H. Christensen, YKL-40 tissue expression and plasma levels in patients with ovarian cancer, BMC Cancer 9 2009; 8. Høgdall E.V. Ringsholt M. Høgdall C.K. Christensen I.J. Johansen J.S. Kjaer S.K. Blaakaer J. Ostenfeld-Møller L. Price P.A. Christensen L.H. , YKL-40 tissue expression and plasma levels in patients with ovarian cancer , BMC Cancer 9 2009 ; 8 . Search in Google Scholar

18. C. Hu, E.C. Polley, S. Yadav, J. Lilyquist, H. Shimelis, J. Na, S.N. Hart, D.E. Goldgar, S. Shah, T. Pesaran, J.S. Dolinsky, H. LaDuca, F.J. Couch, The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort, J Natl Cancer Inst. 2020; 112(12): 1231-1241. Hu C. Polley E.C. Yadav S. Lilyquist J. Shimelis H. Na J. Hart S.N. Goldgar D.E. Shah S. Pesaran T. Dolinsky J.S. LaDuca H. Couch F.J. , The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort , J Natl Cancer Inst. 2020 ; 112 ( 12 ): 1231 - 1241 . Search in Google Scholar

19. E. Fountzilas, I. Konstantopoulou, A. Vagena, P. Apostolou, C. Papadimitriou, C. Christodoulou, D. Tryfonopoulos, K. Manousou, A. Delimitsou, M. Papamentzelopoulou, G. Fountzilas, D. Yannoukakos, F. Fostira, Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections. Clin Breast Cancer.2020; 20(2): 152-59. Fountzilas E. Konstantopoulou I. Vagena A. Apostolou P. Papadimitriou C. Christodoulou C. Tryfonopoulos D. Manousou K. Delimitsou A. Papamentzelopoulou M. Fountzilas G. Yannoukakos D. Fostira F. , Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections . Clin Breast Cancer. 2020 ; 20 ( 2 ): 152 - 59 . Search in Google Scholar

20. Y. Laitman, T.M Friebel, D. Yannoukakos, F. Fostira, I. Konstantopoulou, G. Figlioli, B. Bonanni, S. Manoukian, M. Zuradelli, C. Tondini, B. Pasini, P. Peterlongo, D. Plaseska-Karanfilska, M. Jakimovska, K. Majidzadeh, S. Zarinfam, M.A Loizidou, A. Hadjisavvas, K. Michailidou, K. Kyriacou, D. M Behar, R. B Molho, P. Ganz, P. James, M.T Parsons, A. Sallam, O.I Olopade, A. Seth, G. Chenevix-Trench, G. Leslie, L. McGuffog, M.J Marafie, A. Megarbane, F. Al-Mulla, T.R Rebbeck, E. Friedman, The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries. Hum Mutat. 2019; 40(11): 1-23. Laitman Y. Friebel T.M Yannoukakos D. Fostira F. Konstantopoulou I. Figlioli G. Bonanni B. Manoukian S. Zuradelli M. Tondini C. Pasini B. Peterlongo P. Plaseska-Karanfilska D. Jakimovska M. Majidzadeh K. Zarinfam S. Loizidou M.A Hadjisavvas A. Michailidou K. Kyriacou K. Behar D. M Molho R. B Ganz P. James P. Parsons M.T Sallam A. Olopade O.I Seth A. Chenevix-Trench G. Leslie G. McGuffog L. Marafie M.J Megarbane A. Al-Mulla F. Rebbeck T.R Friedman E. , The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries . Hum Mutat. 2019 ; 40 ( 11 ): 1 - 23 . Search in Google Scholar

21. T. Mitamura, M. Sekine, M. Arai, Y. Shibata, M. Kato, S. Yokoyama, H. Yamashita, H. Watari, I. Yabe, H. Nomura, T. Enomoto, S. Nakamura, The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study, World J Surg Oncol. 2021; 19(1): 36. Mitamura T. Sekine M. Arai M. Shibata Y. Kato M. Yokoyama S. Yamashita H. Watari H. Yabe I. Nomura H. Enomoto T. Nakamura S. , The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study , World J Surg Oncol. 2021 ; 19 ( 1 ): 36 . Search in Google Scholar

22. M. Arts-de Jong, G.H. de Bock, C.J. van Asperen, M.J. Mourits, J.A. de Hullu, C.M. Kets, Germline BRCA 1/BRCA 2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review, Eur J Cancer. 2016; 61: 137-45. Arts-de Jong M. de Bock G.H. van Asperen C.J. Mourits M.J. de Hullu J.A. Kets C.M. , Germline BRCA 1/BRCA 2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review , Eur J Cancer. 2016 ; 61 : 137 - 45 . Search in Google Scholar

23. S.R. Lakhani, S. Manek, F. Penault-Llorca, A. Flanagan, L. Arnout, S. Merrett, L. McGuffog, D. Steele, P. Devilee, J.G. Klijn, H. Meijers-Heijboer, P. Radice, S. Pilotti, H. Nevanlinna, R. Butzow, H. Sobol, J. Jacquemier, D.S. Lyonet, S.L. Neuhausen, B. Weber, T. Wagner, R. Winqvist, Y.J. Bignon, F. Monti, F. Schmitt, G. Lenoir, S. Seitz, U. Hamman, P. Pharoah, G. Lane, B. Ponder, D.T. Bishop, D.F. Easton, Pathology of ovarian cancers in BRCA1 and BRCA2 carriers, Clin Cancer Res. 2004; 10(7): 2473-81. Lakhani S.R. Manek S. Penault-Llorca F. Flanagan A. Arnout L. Merrett S. McGuffog L. Steele D. Devilee P. Klijn J.G. Meijers-Heijboer H. Radice P. Pilotti S. Nevanlinna H. Butzow R. Sobol H. Jacquemier J. Lyonet D.S. Neuhausen S.L. Weber B. Wagner T. Winqvist R. Bignon Y.J. Monti F. Schmitt F. Lenoir G. Seitz S. Hamman U. Pharoah P. Lane G. Ponder B. Bishop D.T. Easton D.F. , Pathology of ovarian cancers in BRCA1 and BRCA2 carriers , Clin Cancer Res. 2004 ; 10 ( 7 ): 2473 - 81 . Search in Google Scholar

24. B.M. Norquist, M.I. Harrell, M.F. Brady, T. Walsh, M.K. Lee, S. Gulsuner, S.S. Bernards, S. Casadei, Q. Yi, R.A. Burger, J.K. Chan, S.A. Davidson, R.S. Mannel, P.A. DiSilvestro, H.A. Lankes, N.C. Ramirez, M.C. King, E.M. Swisher, M.J. Birrer, Inherited Mutations in Women With Ovarian Carcinoma, JAMA Oncol. 2016; 2(4): 482-90. Norquist B.M. Harrell M.I. Brady M.F. Walsh T. Lee M.K. Gulsuner S. Bernards S.S. Casadei S. Yi Q. Burger R.A. Chan J.K. Davidson S.A. Mannel R.S. DiSilvestro P.A. Lankes H.A. Ramirez N.C. King M.C. Swisher E.M. Birrer M.J. , Inherited Mutations in Women With Ovarian Carcinoma , JAMA Oncol. 2016 ; 2 ( 4 ): 482 - 90 . Search in Google Scholar

25. K.L. Bolton, G. Chenevix-Trench, C. Goh, S. Sadetzki, S.J. Ramus, B.Y. Karlan, D. Lambrechts, E. Despierre, D. Barrowdale, L. McGuffog, S. Healey, D.F. Easton, O. Sinilnikova, J. Benítez, M.J. García, S. Neuhausen, M.H. Gail, P. Hartge, S. Peock, D. Frost, D.G. Evans, R. Eeles, A.K. Godwin, M.B. Daly, A. Kwong, E.S. Ma, C. Lázaro, I. Blanco, M. Montagna, E. D’Andrea, M.O. Nicoletto, S.E. Johnatty, S.K. Kjær, A. Jensen, E. Høgdall, E.L. Goode, B.L. Fridley, J.T. Loud, M.H. Greene, P.L. Mai, A. Chetrit, F. Lubin, G. Hirsh-Yechezkel, G. Glendon, I.L. Andrulis, A.E. Toland, L. Senter, M.E. Gore, C. Gourley, C.O. Michie, H. Song, J. Tyrer, A.S. Whittemore, V. McGuire, W. Sieh, U. Kristoffersson, H. Olsson, Å. Borg, D.A. Levine, L. Steele, M.S. Beattie, S. Chan, R.L. Nussbaum, K.B. Moysich, J. Gross, I. Cass, C. Walsh, A.J. Li, R. Leuchter, O. Gordon, M. Garcia-Closas, S.A. Gayther, S.J. Chanock, A.C. Antoniou, P.D. Pharoah, Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer, Jama. 2012; 307(4): 382-90. Bolton K.L. Chenevix-Trench G. Goh C. Sadetzki S. Ramus S.J. Karlan B.Y. Lambrechts D. Despierre E. Barrowdale D. McGuffog L. Healey S. Easton D.F. Sinilnikova O. Benítez J. García M.J. Neuhausen S. Gail M.H. Hartge P. Peock S. Frost D. Evans D.G. Eeles R. Godwin A.K. Daly M.B. Kwong A. Ma E.S. Lázaro C. Blanco I. Montagna M. D’Andrea E. Nicoletto M.O. Johnatty S.E. Kjær S.K. Jensen A. Høgdall E. Goode E.L. Fridley B.L. Loud J.T. Greene M.H. Mai P.L. Chetrit A. Lubin F. Hirsh-Yechezkel G. Glendon G. Andrulis I.L. Toland A.E. Senter L. Gore M.E. Gourley C. Michie C.O. Song H. Tyrer J. Whittemore A.S. McGuire V. Sieh W. Kristoffersson U. Olsson H. Borg Å. Levine D.A. Steele L. Beattie M.S. Chan S. Nussbaum R.L. Moysich K.B. Gross J. Cass I. Walsh C. Li A.J. Leuchter R. Gordon O. Garcia-Closas M. Gayther S.A. Chanock S.J. Antoniou A.C. Pharoah P.D. , Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer , Jama. 2012 ; 307 ( 4 ): 382 - 90 . Search in Google Scholar

26. A. Chetrit, G. Hirsh-Yechezkel, Y. Ben-David, F. Lubin, E. Friedman, S. Sadetzki, Effect of BRCA 1/ BRCA 2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer, J Clin Oncol. 2008; 26(1): 20-5. Chetrit A. Hirsh-Yechezkel G. Ben-David Y. Lubin F. Friedman E. Sadetzki S. , Effect of BRCA 1/BRCA 2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer , J Clin Oncol. 2008 ; 26 ( 1 ): 20 - 5 . Search in Google Scholar

27. D.S. Tan, C. Rothermundt, K. Thomas, E. Bancroft, R. Eeles, S. Shanley, A. Ardern-Jones, A. Norman, S.B. Kaye, M.E. Gore, “BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations, J Clin Oncol. 2008; 26(34): 5530-6. Tan D.S. Rothermundt C. Thomas K. Bancroft E. Eeles R. Shanley S. Ardern-Jones A. Norman A. Kaye S.B. Gore M.E. , “BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations , J Clin Oncol. 2008 ; 26 ( 34 ): 5530 - 6 . Search in Google Scholar

28. D. Yang, S. Khan, Y. Sun, K. Hess, I. Shmulevich, A.K. Sood, W. Zhang, Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer, Jama. 2011; 306(14): 1557-65. Yang D. Khan S. Sun Y. Hess K. Shmulevich I. Sood A.K. Zhang W. , Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer , Jama. 2011 ; 306 ( 14 ): 1557 - 65 . Search in Google Scholar

29. C.C. Pritchard, J. Mateo, M.F. Walsh, N. De Sarkar, W. Abida, H. Beltran, A. Garofalo, R. Gulati, S. Carreira, R. Eeles, O. Elemento, M.A. Rubin, D. Robinson, R. Lonigro, M. Hussain, A. Chinnaiyan, J. Vinson, J. Filipenko, L. Garraway, M.E. Taplin, S. AlDubayan, G.C. Han, M. Beightol, C. Morrissey, B. Nghiem, H.H. Cheng, B. Montgomery, T. Walsh, S. Casadei, M. Berger, L. Zhang, A. Zehir, J. Vijai, H.I. Scher, C. Sawyers, N. Schultz, P.W. Kantoff, D. Solit, M. Robson, E.M. Van Allen, K. Offit, J. de Bono, P.S. Nelson, Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer, N Engl J Med. 2016; 375(5): 443-53. Pritchard C.C. Mateo J. Walsh M.F. De Sarkar N. Abida W. Beltran H. Garofalo A. Gulati R. Carreira S. Eeles R. Elemento O. Rubin M.A. Robinson D. Lonigro R. Hussain M. Chinnaiyan A. Vinson J. Filipenko J. Garraway L. Taplin M.E. AlDubayan S. Han G.C. Beightol M. Morrissey C. Nghiem B. Cheng H.H. Montgomery B. Walsh T. Casadei S. Berger M. Zhang L. Zehir A. Vijai J. Scher H.I. Sawyers C. Schultz N. Kantoff P.W. Solit D. Robson M. Van Allen E.M. Offit K. de Bono J. Nelson P.S. , Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer , N Engl J Med. 2016 ; 375 ( 5 ): 443 - 53 . Search in Google Scholar

30. E. Castro, C. Goh, D. Olmos, E. Saunders, D. Leongamornlert, M. Tymrakiewicz, N. Mahmud, T. Dadaev, K. Govindasami, M. Guy, E. Sawyer, R. Wilkinson, A. Ardern-Jones, S. Ellis, D. Frost, S. Peock, D.G. Evans, M. Tischkowitz, T. Cole, R. Davidson, D. Eccles, C. Brewer, F. Douglas, M.E. Porteous, A. Donaldson, H. Dorkins, L. Izatt, J. Cook, S. Hodgson, M.J. Kennedy, L.E. Side, J. Eason, A. Murray, A.C. Antoniou, D.F. Easton, Z. Kote-Jarai, R. Eeles, Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer, J Clin Oncol. 2013; 31(14): 1748-57. Castro E. Goh C. Olmos D. Saunders E. Leongamornlert D. Tymrakiewicz M. Mahmud N. Dadaev T. Govindasami K. Guy M. Sawyer E. Wilkinson R. Ardern-Jones A. Ellis S. Frost D. Peock S. Evans D.G. Tischkowitz M. Cole T. Davidson R. Eccles D. Brewer C. Douglas F. Porteous M.E. Donaldson A. Dorkins H. Izatt L. Cook J. Hodgson S. Kennedy M.J. Side L.E. Eason J. Murray A. Antoniou A.C. Easton D.F. Kote-Jarai Z. Eeles R. , Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer , J Clin Oncol. 2013 ; 31 ( 14 ): 1748 - 57 . Search in Google Scholar

31. R. Na, S.L. Zheng, M. Han, H. Yu, D. Jiang, S. Shah, C.M. Ewing, L. Zhang, K. Novakovic, J. Petkewicz, K. Gulukota, D.L. Helseth, Jr., M. Quinn, E. Humphries, K.E. Wiley, S.D. Isaacs, Y. Wu, X. Liu, N. Zhang, C.H. Wang, J. Khandekar, P.J. Hulick, D.H. Shevrin, K.A. Cooney, Z. Shen, A.W. Partin, H.B. Carter, M.A. Carducci, M.A. Eisenberger, S.R. Denmeade, M. McGuire, P.C. Walsh, B.T. Helfand, C.B. Brendler, Q. Ding, J. Xu, W.B. Isaacs, Germline Mutations in ATM and BRCA 1/BRCA 2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death, Eur Urol. 2017; 71(5): 740-747. Na R. Zheng S.L. Han M. Yu H. Jiang D. Shah S. Ewing C.M. Zhang L. Novakovic K. Petkewicz J. Gulukota K. Helseth D.L. Jr. Quinn M. Humphries E. Wiley K.E. Isaacs S.D. Wu Y. Liu X. Zhang N. Wang C.H. Khandekar J. Hulick P.J. Shevrin D.H. Cooney K.A. Shen Z. Partin A.W. Carter H.B. Carducci M.A. Eisenberger M.A. Denmeade S.R. McGuire M. Walsh P.C. Helfand B.T. Brendler C.B. Ding Q. Xu J. Isaacs W.B. , Germline Mutations in ATM and BRCA 1/BRCA 2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death , Eur Urol. 2017 ; 71 ( 5 ): 740 - 747 . Search in Google Scholar

32. E. Castro, N. Romero-Laorden, A. Del Pozo, R. Lozano, A. Medina, J. Puente, J.M. Piulats, D. Lorente, M.I. Saez, R. Morales-Barrera, E. Gonzalez-Billalabeitia, Y. Cendón, I. García-Carbonero, P. Borrega, M.J. Mendez Vidal, A. Montesa, P. Nombela, E. Fernández-Parra, A. Gonzalez Del Alba, J.C. Villa-Guzmán, K. Ibáñez, A. Rodriguez-Vida, L. Magraner-Pardo, B. Perez-Valderrama, E. Vallespín, E. Gallardo, S. Vazquez, C.C. Pritchard, P. Lapunzina, D. Olmos, PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer, J Clin Oncol. 2019; 37(6): 490-503. Castro E. Romero-Laorden N. Del Pozo A. Lozano R. Medina A. Puente J. Piulats J.M. Lorente D. Saez M.I. Morales-Barrera R. Gonzalez-Billalabeitia E. Cendón Y. García-Carbonero I. Borrega P. Mendez Vidal M.J. Montesa A. Nombela P. Fernández-Parra E. Gonzalez Del Alba A. Villa-Guzmán J.C. Ibáñez K. Rodriguez-Vida A. Magraner-Pardo L. Perez-Valderrama B. Vallespín E. Gallardo E. Vazquez S. Pritchard C.C. Lapunzina P. Olmos D. , PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer , J Clin Oncol. 2019 ; 37 ( 6 ): 490 - 503 . Search in Google Scholar

33. J. Mateo, S. Carreira, S. Sandhu, S. Miranda, H. Mossop, R. Perez-Lopez, D. Nava Rodrigues, D. Robinson, A. Omlin, N. Tunariu, G. Boysen, N. Porta, P. Flohr, A. Gillman, I. Figueiredo, C. Paulding, G. Seed, S. Jain, C. Ralph, A. Protheroe, S. Hussain, R. Jones, T. Elliott, U. McGovern, D. Bianchini, J. Goodall, Z. Zafeiriou, C.T. Williamson, R. Ferraldeschi, R. Riisnaes, B. Ebbs, G. Fowler, D. Roda, W. Yuan, Y.M. Wu, X. Cao, R. Brough, H. Pemberton, R. A’Hern, A. Swain, L.P. Kunju, R. Eeles, G. Attard, C.J. Lord, A. Ashworth, M.A. Rubin, K.E. Knudsen, F.Y. Feng, A.M. Chinnaiyan, E. Hall, J.S. de Bono, DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer, N Engl J Med. 2015; 373(18): 1697-708. Mateo J. Carreira S. Sandhu S. Miranda S. Mossop H. Perez-Lopez R. Nava Rodrigues D. Robinson D. Omlin A. Tunariu N. Boysen G. Porta N. Flohr P. Gillman A. Figueiredo I. Paulding C. Seed G. Jain S. Ralph C. Protheroe A. Hussain S. Jones R. Elliott T. McGovern U. Bianchini D. Goodall J. Zafeiriou Z. Williamson C.T. Ferraldeschi R. Riisnaes R. Ebbs B. Fowler G. Roda D. Yuan W. Wu Y.M. Cao X. Brough R. Pemberton H. A’Hern R. Swain A. Kunju L.P. Eeles R. Attard G. Lord C.J. Ashworth A. Rubin M.A. Knudsen K.E. Feng F.Y. Chinnaiyan A.M. Hall E. de Bono J.S. , DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer , N Engl J Med. 2015 ; 373 ( 18 ): 1697 - 708 . Search in Google Scholar

34. J. Mateo, N. Porta, D. Bianchini, U. McGovern, T. Elliott, R. Jones, I. Syndikus, C. Ralph, S. Jain, M. Varughese, O. Parikh, S. Crabb, A. Robinson, D. McLaren, A. Birtle, J. Tanguay, S. Miranda, I. Figueiredo, G. Seed, C. Bertan, P. Flohr, B. Ebbs, P. Rescigno, G. Fowler, A. Ferreira, R. Riisnaes, R. Pereira, A. Curcean, R. Chandler, M. Clarke, B. Gurel, M. Crespo, D. Nava Rodrigues, S. Sandhu, A. Espinasse, P. Chatfield, N. Tunariu, W. Yuan, E. Hall, S. Carreira, J.S. de Bono, Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial, Lancet Oncol. 2020; 21(1): 162-174. Mateo J. Porta N. Bianchini D. McGovern U. Elliott T. Jones R. Syndikus I. Ralph C. Jain S. Varughese M. Parikh O. Crabb S. Robinson A. McLaren D. Birtle A. Tanguay J. Miranda S. Figueiredo I. Seed G. Bertan C. Flohr P. Ebbs B. Rescigno P. Fowler G. Ferreira A. Riisnaes R. Pereira R. Curcean A. Chandler R. Clarke M. Gurel B. Crespo M. Nava Rodrigues D. Sandhu S. Espinasse A. Chatfield P. Tunariu N. Yuan W. Hall E. Carreira S. de Bono J.S. , Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial , Lancet Oncol. 2020 ; 21 ( 1 ): 162 - 174 . Search in Google Scholar

35. J. de Bono, J. Mateo, K. Fizazi, F. Saad, N. Shore, S. Sandhu, K.N. Chi, O. Sartor, N. Agarwal, D. Olmos, A. Thiery-Vuillemin, P. Twardowski, N. Mehra, C. Goessl, J. Kang, J. Burgents, W. Wu, A. Kohlmann, C.A. Adelman, M. Hussain, Olaparib for Metastatic Castration-Resistant Prostate Cancer, N Engl J Med. 2020; 382(22): 2091-2102. de Bono J. Mateo J. Fizazi K. Saad F. Shore N. Sandhu S. Chi K.N. Sartor O. Agarwal N. Olmos D. Thiery-Vuillemin A. Twardowski P. Mehra N. Goessl C. Kang J. Burgents J. Wu W. Kohlmann A. Adelman C.A. Hussain M. , Olaparib for Metastatic Castration-Resistant Prostate Cancer , N Engl J Med. 2020 ; 382 ( 22 ): 2091 - 2102 . Search in Google Scholar

36. D.R. Berthold, G.R. Pond, F. Soban, R. de Wit, M. Eisenberger, I.F. Tannock, Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study, J Clin Oncol. 2008; 26(2): 242-5. Berthold D.R. Pond G.R. Soban F. de Wit R. Eisenberger M. Tannock I.F. , Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study , J Clin Oncol. 2008 ; 26 ( 2 ): 242 - 5 . Search in Google Scholar

37. K.M. Murphy, K.A. Brune, C. Griffin, J.E. Sollenberger, G.M. Petersen, R. Bansal, R.H. Hruban, S.E. Kern, Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%, Cancer Res. 2002; 62(13): 3789-93. Murphy K.M. Brune K.A. Griffin C. Sollenberger J.E. Petersen G.M. Bansal R. Hruban R.H. Kern S.E. , Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17% , Cancer Res. 2002 ; 62 ( 13 ): 3789 - 93 . Search in Google Scholar

38. Cancer risks in BRCA2 mutation carriers, J Natl Cancer Inst. 1999; 91(15): 1310-6. Cancer risks in BRCA2 mutation carriers , J Natl Cancer Inst. 1999 ; 91 ( 15 ): 1310 - 6 . Search in Google Scholar